1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Substance Use Prevention, Treatment, & Recovery Services Block Grant (SUPTRS BG) is sponsored by Ohio Department of Behavioral Health (DBH). This block grant, received from SAMHSA, provides Ohio with flexibility to design and implement activities and services addressing the complex needs of individuals, families, and communities affected by substance use disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Primarily Ohio's 50 Alcohol, Drug, and Mental Health Service Boards, who then contract with local entities including nonprofits to provide services. Nonprofits should connect with their local ADAMH board. Confirm the full requirements in the official notice before applying.
Substance Use Prevention, Treatment, & Recovery Services Block Grant (SUPTRS BG) is funded by Ohio Department of Behavioral Health (DBH). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Ohio. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
BJA opened five FY2026 competitions covering reentry, family-based substance use treatment, opioid response and crisis stabilization, with award ceilings from $1 million to $3 million. Grants.gov closes September 24 and 25; JustGrants closes October 1 and 2. The seven-day gap between them is the single most common reason a finished DOJ application never gets reviewed.
Read articleARPA-H selected 13 research teams for EVIDENT, a $139.4M initiative to develop objective clinical endpoints for rapid-acting behavioral health therapies including psilocybin. At least $50M will match state psychedelic research investments under a Trump executive order.
Read articleARPA-H's $139.4M EVIDENT initiative selects 13 research teams to build objective biomarkers for psilocybin, neuromodulation, and rapid-acting mental health therapies.
Read article